Correlation of total serum HDL particles with a predictor of mortality risk in idiopathic pulmonary fibrosis. Issue 4 (14th April 2022)

• Record Type: Journal Article
• Authors: Yasuma, Taro; D'Alessandro-Gabazza, Corina N.; Fujimoto, Hajime; Kobayashi, Tetsu; Gabazza, Esteban C.
• Is Part Of: European respiratory journal. Volume 59:Issue 4(2022)
• Publication Date: 2022-04-14
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.03175-2021
• Languages: English
• ISSNs: 0903-1936

Abstract

We read with great interest the article published in your journal by Barochia et al . [1]. The authors reported that the serum level of small high-density lipoprotein particles measured by nuclear magnetic resonance spectroscopy (S-HDLPNMR ) is negatively associated with death or lung transplantation in idiopathic pulmonary fibrosis (IPF) [1]. The finding is consistent with the protective activity of high-density lipoprotein (HDL) in tissue injury and fibrosis reported in previous studies [2–5]. Measurement of serum total HDL particles may be potentially useful as a biomarker in idiopathic pulmonary fibrosis https://bit.ly/3K7D3q6